Go to the About Us section
Go to the Courses section
Go to the Research section
Go to the Specialist Services & Consultancy section
Go to the Outreach section
Go to the New Students section
Scientific analysis of a protein enzyme found in COVID-19 could lead to the development of new drugs to treat the virus, research led by Oxford Brookes University scientists has found.
Oxford Brookes University is extending its international reach and impact with a new partnership in Sri Lanka, delivering degree programmes with the British College of Applied Studies (BCAS Campus).
Ariadna Picart-Picolo, Frederic Pontvianne and colleagues have published a paper in Genome Research that was supported by the INDEPTH Cost Action.
Numerous animals may be vulnerable to SARS-CoV-2, the virus that causes Covid-19, according to a large study modelling how the virus might infect different animals’ cells, involving Oxford Brookes University academics.
We are generating a set of resources for INDEPTH members (and others) to use in their research and teaching.
A new COST Action launches in September 2020 that has great relevance to INDEPTH members!
Oxford Brookes spinout company Oxford Expression Technologies has been awarded a grant from Innovate UK to support a partnership with Vaxine Pty Ltd to develop a vaccine for COVID-19.
We are delighted to report on the publication of the JXBot special issue on 'Impact of Chromatin Domains on Plant Phenotypes'.
As a Faculty we are very proud of our diverse research student community, comprising 131 PhD students, 2 MPhil students, 8 masters by research students, 2 PhD by published works and 27 students on our Professional Doctorate in Nursing.